Metergoline

This classification denotes a chemotherapy regimen in current use with the molecular formula C25H29N3O2, a preparation that US FDA recognizes as an active ingredient or moiety under Unique Ingredient Identifier 1501393LY5, chemically known as 1,6-dimethyl-8-beta-carbobenzyloxaminomethyl-10-alpha-ergoline but more generally known as metergoline, which bears U.S. NIH Compound Identifier 28693. European Medicines Agency schedules Metergoline in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB08824MIG. The term METERGOLINE is an International Non-Proprietary Name or INN (see World Health Organization INN reference publication, Volume 22, No. 10, 1968, List 8). World Health Organization schedules metergoline in its Anatomical Therapeutic Chemical (ATC) Classification and its WHO-DD or Drug Dictionary. METERGOLINE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix.